EG
Therapeutic Areas
NeuroEM Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| MemorEM | Alzheimer's Disease | Phase 2 |
Leadership Team at NeuroEM Therapeutics
CP
Chuck Papageorgiou
Chief Executive & Technical Officer
WS
William Scott Burgin, MD
Chief Medical Officer
CC
Chuanhai Cao, PhD
Head of USF Research Team
TI
Tracy Ingram
Chief Operating & Information Officer
MT
Marilyn Thompson
Chief Financial Officer
GA
Gary Arendash, PhD
Founder & Scientist Emeritus